Clinical trials located in


Cracow city is located in Poland. Currently, 1 clinical trials are being conducted in this city.

  • CT-EU-00117951

    Study of Adalimumab and Risankizumab in the treatment of juvenile psoriatic arthritis in children

    This clinical trial is evaluating the safety and effectiveness of Risankizumab in the treatment of juvenile arthritis with psoriasis in children. It is a type of arthritis in which the immune system attacks healthy cells and tissues, causing pain, stiffness and swelling in the joints.

    About 40 young participants with juvenile psoriatic arthritis will be randomized to receive Risankizumab or the already approved treatment Adalimumab. Participants will receive medications in the form of subcutaneous injections for 24 weeks. Those who find the treatment effective will continue for another 100 weeks.

    During the study, participants will regularly visit a hospital or clinic where they will undergo medical tests, blood tests, check for side effects and complete questionnaires. This allows us to assess the effectiveness and safety of risankizumab in the treatment of juvenile psoriatic arthritis in children.

    • Risankizumab
    • Adalimumab

See more clinical trials in other cities in Poland: